TARGETING MNK/GRP78 PATHWAY TO DISRUPT PROTEOSTASIS REWIRING IN CASTRATION-RESISTANT PROSTATE CANCER

$1,602,137FY2025Defense Health AgencyDOD

University Of Kentucky Research Foundation, The

Investigators